Leaflet PRIMOVIST 0.25mmol/ml 181.430mg solution for injection in pre-filled syringe


Indicated for: diagnostic imaging contrast enhancement

Route of administration: injectable

Substance: gadoxetic acid (contrast agent)

ATC: V08CA10 (Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media)

Gadoxetic acid is a contrast agent used in magnetic resonance imaging (MRI), particularly for liver evaluation. It contains gadolinium, a metal that helps improve the clarity of MRI images.

It is commonly used for diagnosing liver lesions, including tumors or other hepatic conditions. Administration is done intravenously, and the substance is eliminated from the body through the kidneys and liver.

Side effects are rare but may include nausea, headaches, or allergic reactions. In patients with severe renal impairment, there is a very small risk of nephrogenic systemic fibrosis.

Patients should inform their doctor about any kidney or liver conditions before administration. The use of this contrast agent should be supervised by a specialist to minimize risks.

General data about PRIMOVIST 0.25mmol/ml 181.430mg

  • Substance: gadoxetic acid
  • Date of last drug list: 01-05-2026
  • Commercial code: W63890007
  • Concentration: 181.430mg
  • Pharmaceutical form: solution for injection in pre-filled syringe
  • Packing volume: 10 ml
  • Product type: original
  • Price: 677.84 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: BAYER AG - GERMANIA
  • Holder: BAYER AG - GERMANIA
  • Number: 13707/2021/01
  • Shelf life: 5 years

Pharmaceutical forms available for gadoxetic acid

Concentrations available for gadoxetic acid

  • 181.430mg
  • 181.43mg/ml